RxDoctor Payments Data

Patrick Jenkins, MD

Family Medicine · Indian Land, SCNPI 1750795183

Payments from drug & device makers

$423in general payments, 2019–2025

Across 23 payments — averaging $18.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$109
  • AstraZeneca$66
  • Boehringer Ingelheim$50
  • Pfizer$42
  • Novo Nordisk$39
  • Novartis$37
  • plus $80 from 5 others

What the payments were for

  • Food & beverage$40996%
  • Education$154%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$423 in reported general payments places this provider in the 45th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$137,691
Medicare patients
348
Services billed
2,487

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$80,552
EliquisApixaban62$68,829
JardianceEmpagliflozin37$37,381
TrulicityDulaglutide16$36,131
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$23,338
FarxigaDapagliflozin Propanediol19$17,929
MounjaroTirzepatide13$13,459
JanuviaSitagliptin Phosphate14$10,419
Combivent RespimatIpratropium/Albuterol Sulfate12$5,775
Atorvastatin Calcium424$3,112
Gabapentin91$2,920
Albuterol Sulfate HfaAlbuterol Sulfate64$1,852
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$1,430
Levothyroxine Sodium184$1,420
Fluticasone Propionate83$1,399

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$39$80,55256 claims
PfizerEliquis$42$68,82962 claims
Lilly USA, LLCTrulicity, Mounjaro$13$49,59029 claims
Boehringer IngelheimJardiance, Combivent Respimat$50$43,15649 claims
AstraZenecaFarxiga$66$17,92919 claims
MerckJanuvia$11$10,41914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Indian Land

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →